Potential tumor or organ-imaging agents, 24. Radioiodinated pregnenolone esters.
A series of radioiodinated pregnenolone esters was prepared in an effort to find an agent that would be rapidly and selectively taken up by adrenal cortical tissue. Achievement of such a goal would provide the basis for the development of an adrenal imaging agent having several advantages over those agents currently available for clinical use. The radioiodinated esters for this study were readily prepared by treating pregnenolone with the appropriate iodobenzoic acid in the presence of dicyclohexylcarbodiimide (DCC) and 4-dimethylamino-pyridine (DMAP). The resulting esters were readily labeled with radioiodine by isotope exchange with sodium iodide-125 in pivalic acid. Subsequent tissue distribution studies in rats revealed that those esters displaying the most stability towards hydrolysis achieved the highest concentration in adrenal cortical tissue. For example, the 2,3,5-triiodobenzoate (6) showed an adrenal uptake of 23% of administered dose per gram of tissue at 0.5 hours. The achievement of high levels of radioactivity in the adrenal with this agent at early time periods warrants further evaluation of this agent in other animals.
D000302:Adrenal Cortex / Q000000981:diagnostic imaging*; D000306:Adrenal Cortex Neoplasms / Q000000981:diagnostic imaging*; D000818:Animals; D005260:Female; D007457:Iodine Radioisotopes; D007463:Iodobenzoates / Q000138:chemical synthesis; D011284:Pregnenolone / Q000031:analogs & derivatives* / Q000138:chemical synthesis; D011877:Radionuclide Imaging; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D007457:Iodine Radioisotopes; D007463:Iodobenzoates; D011284:Pregnenolone